COVID-19 Vaccine Information

Do you need to reset your CVMS Portal password? Click here for instructions

Other providers are now offering the COVID-19 vaccine.
To find a provider Click Here.

Cabarrus Health Alliance's is currently vaccinating all individuals 12 and older.

Click to Here Schedule a 1st or 2nd Dose COVID-19 Vaccine Appointment

CHA COVID-19 Vaccine Schedule

August 5Boys and Girls Club247 Spring St NW, Concord, NC3:00pm - 7:00pm
August 9Performance Learning Center4521 Weddington Rd, Concord, NC12:00pm - 6:00pm
August 12Cabarrus Health Alliance300 Mooresville Rd, Kannapolis, NC2:00pm - 6:00pm

Walk-ins welcome, appointments optional.

For transportation assistance to a COVID-19 Vaccine Clinic 704-920-2246.

For homebound individuals or those having issues scheduling a COVID-19 vaccine appointment please call CHA's Call Center at 704-920-1213.

Before you come, please:

  1. Print and bring your completed 1st Dose Registration Form with you. (Spanish)
    2nd Dose Registration Form (Spanish)
  2. Bring a copy of your insurance card (front and back). Insurance is not required and there will be no out-of-pocket cost to any patient. 
    1. If you have Medicare, please bring or complete your registration form with your standard or base plan Medicare ID  information.
  3. (First Dose ONLY) If you scheduled your first dose appointment online through CHA's electronic medical record (EMR), Novel Health, please bring your Novel Health account username and password to your first dose appointment. You will need your account information to schedule your second dose appointment.

Second Dose Appointment Scheduling 

CHA will be opening second dose appointments on Monday, January 18, 2021. Individuals who have already received their first dose, were given a ‘COVID-19 Vaccination Record Card’. The date on the back of that card is NOT an appointment, it is the first day the patient is eligible to receive their second dose:

  • Pfizer second dose can be administered as early as 21 days after the first dose
  • Moderna second dose can be administered as early as 28 days after the first dose

Health officials are asking individuals who received their first dose to monitor the COVID-19 Vaccine website for clinic dates that are on or after the date listed on the back of their ‘COVID-19 Vaccination Record Card’.

If you received your first dose with another provider, we encourage you to please return to the same provider for your second dose. Thank you


  • Walk-ins welcome, appointments optional
  • Proof of residency is not required, but please consider attending a vaccine clinic in your community.
  • If you have received any other vaccine in the last 14 days you are not eligible to receive the COVID-19 vaccine.
  • Individuals who have cancer and are actively receiving chemotherapy treatment or radiation, as well as persons with rheumatoid arthritis and are undergoing treatment with drugs, such as methotrexate should seek guidance from their primary care provider before receiving a COVID-19 vaccine.
  • Immigration status is not shared with anyone; however name and demographics are submitted to the North Carolina Department of Health and Human Services (NC DHHS) COVID Vaccine Management System (CVMS).

Tested, safe, and effective COVID-19 vaccines will help us defeat the virus, get back in control of our lives, and back to the people and places we love. Get the COVID-19 Vaccine Facts and Update from the North Carolina Department of Health and Human Services - For more information Click Here.
Para mucha más información en español acerca de las vacunas del Covid-19, visite:

COVID-19 Vaccine Emergency Use Authorization and Fact Sheets

For each COVID-19 vaccine authorized under an Emergency Use Authorization (EUA), the Food and Drug Administration (FDA) requires that vaccine recipients or their caregivers are provided with certain vaccine-specific EUA information to help make an informed decision about vaccination. This is accomplished by providing a an EUA Fact Sheet for Recipients and Caregivers. The Fact Sheet is similar in purpose and content to vaccine information statements (VISs) for licensed vaccines but differs in that the EUA Fact Sheet is specific to each authorized COVID-19 vaccine, is developed by the manufacturer of the vaccine, and is authorized by the FDA.

vaccine goal meter 7.30.21